Navigation Links
NeoStem Expands Stem Cell Collection Center Network Into New Jersey Led by Leading Plastic Surgeon and Anti-Aging Authority
Date:3/19/2009

NEW YORK, March 19 /PRNewswire-FirstCall/ -- NeoStem, Inc. (NYSE Alternext US: NBS), which is pioneering the pre-disease collection, processing and long-term storage of adult stem cells for future medical need, announced today it has signed an agreement with Dr. Vincent C. Giampapa, M.D., F.A.C.S. to open a new stem cell collection center at the Giampapa Institute for Anti-Aging Medical Therapy in Montclair, New Jersey. The agreement adds to NeoStem's national network of metropolitan stem cell collection centers, the most recent of which was in New York City. In February 2009, NeoStem announced it has licensed the exclusive worldwide rights to Dr. Giampapa's innovative stem cell technology and applications for cosmetic facial and body procedures and skin rejuvenation. Dr. Giampapa is a Board-certified plastic reconstructive surgeon and Assistant Clinical Professor of Plastic and Reconstructive Surgery at the University of Medicine and Dentistry of New Jersey. One of the first certified anti-aging medical physicians in the world, he is Director of the Plastic Surgery Center Internationale as well as The Giampapa Institute.

Dr. Giampapa is renowned for a non-surgical complete facial rejuvenation procedure that involves the use of adult stem cells. The procedure can be accomplished under local anesthesia in an office setting and requires only about a week of recovery time. He is also a founder of Suracell Inc. (www.suracell.com), which formulates for clients a personal genetic health program based on analysis of an individual's genetic profile. "We are currently performing Stem Cell Face Lifts and are looking forward to giving our patients the opportunity to have their stem cells collected today for multiple treatments in the future," said Dr. Giampapa.

NeoStem's collection centers utilize a minimally invasive proprietary system to enable health conscious consumer
'/>"/>

SOURCE NeoStem, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. NeoStem Obtains Exclusive Worldwide License to Innovative Stem Cell Technology and Applications for Anti-Aging Skin Rejuvenation Therapies
2. NeoStem Receives Notice of Noncompliance from NYSE Alternext US
3. NeoStems New York City Adult Stem Cell Collection Center Has Opened and Begun Collections
4. NeoStem Completes $500,000 Private Placement With Strategic Investor
5. NeoStem, Inc. to Enter the Regenerative Medicine Market in Asia
6. NeoStem Secures $250,000 in an Above Market Financing and Expands Its Relationship With New England Cryogenic Center, Inc.
7. Suzanne Somers, Renowned Author, Medical Advocate, and Official Spokesperson for NeoStem, Inc., Inspires the Audience on The Ellen Degeneres Show
8. NeoStem Forges Ahead in Its Plan to Open Adult Stem Cell Collection Centers in Key Locations that Can Serve as Hubs to Service Clients Nationwide
9. NeoStem Expands Adult Stem Cell Collection Network, Gains Footprint in Key Los Angeles Market and Initiates Waitlist
10. Suzanne Somers To Promote Growing Importance of Storing Your Own Adult Stem Cells Under Alliance With NeoStem, Inc.
11. NeoStem Announces Private Placement Financing to Advance Marketing Campaign; Financing Includes Investment from New England Cryogenic Center

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... Ambassador to also Visit Detroit , ...,Who: David Appia, French Ambassador for Internati...t in France Agency, , , , ,What: Ambassador Appia... pro-business initiatives adopted by France to fur...ndscape for innovation and development., , ,When: ...
(Date:11/24/2009)...alif.,Nov.24/PRNewswire/--Twomoreprestigiousuniver...onlinejobboardandcareerssiteforlifescienceprofessi...owmembersofthejobboard,joining28othermajorlifescie...ocareercenter.com ,isonlyforpost-graduatesinthelif...sitesontheInternet,BioCareerCenteristheonlyonethat...
(Date:11/24/2009)...celand,November24/PRNewswire-FirstCall/--deCODE,ge...eceivednoticefrom,theNasdaqStockMarketthattradingi...er30,2009andaForm25-NSEwillbefiledwiththe,Securiti...monstock,fromlistingonNasdaq,unlessthecompanyfiles...companyhasfiledsuchanappeal,which,willstaythesuspe...
(Date:11/24/2009)... Health care employment grew by 29,000 job...o show consistent growth during the U.S. recession...in trouble, and health systems are coming closer t...d of just administrators. , ...ment continued growing in October despite the shed...
Breaking Biology Technology:Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4
...TENTS ISSUED IN U.S. AND EUROPE FOR TECHNOLOGY USE...CULAR DIAGNOSTIC PRODUCT LINE , , DENVER, Jan. 20...: CONX), a worldwide developer and marketer of dia...o new patents for technology to which Corgenix hol... Japan. The technology is incorporated in the com...
...L, Wash., Jan. 20 SCOLR Pharma, Inc. (Amex: DDD...ministration (FDA) has issued a Complete Response ...NDA) for pseudoephedrine. The application, filed ...et a 120 mg 12 hour pseudoephedrine tablet based o...(R)) platform. , , The Complete Response letter ...
...SEPH, Mich., Jan. 20 GeneGo, Inc., the leading sy...the Department of Energy,s Pacific Northwest Nati...eGo Center of Excellence. PNNL researchers will h...ata analysis suite, training and advanced support....ess complex national challenges in fundamental sci...
Other Biology Technology:Corgenix Receives Two Additional Patents on AtherOx(R) Technology 2Corgenix Receives Two Additional Patents on AtherOx(R) Technology 3FDA Issues Complete Response Letter to SCOLR Pharma's Abbreviated New Drug Application for CDT(R) 12-Hour Pseudoephedrine 2FDA Issues Complete Response Letter to SCOLR Pharma's Abbreviated New Drug Application for CDT(R) 12-Hour Pseudoephedrine 3Pacific Northwest National Laboratories Becomes a GeneGo Center of Excellence 2
(Date:11/24/2009)...en prescribed by traditional healers in Brazil to ...ch pain to fever and flu. , Now for the first tim...ble to scientifically prove the pain relieving pro...azilian mint. , Testing this ancient South Americ...la Rocha was able to show that when prepared as a ...
(Date:11/24/2009)...ors to understanding how sounds associated with Na...al or if they hear it at all. , The same type o...uses to detect flaws in the space shuttle,s behemo...o peek inside the giant head of a whale. The scans... of a whale,s hearing anatomy using a breakthrough...
(Date:11/24/2009)...abby arteries from collapsing have been true life-...longer needed -- once the arteries are strengthene...d no choice but to leave them in place. , Prof. ...nt of Biomedical Engineering has developed a new p...ere they,re needed, then dissolves. , "Our new c...
Breaking Biology News(10 mins):Got a pain? -- Have a cup of Brazilian mint 2Rocket science leads to new whale discovery 2A coating for life 2Peregrine Pharmaceuticals Reports 61 25 Objective Response Rate in 46 Patient Bavituximab Phase II Trial in Advanced Breast Cancer 5636 1Peregrine Pharmaceuticals Reports 61 25 Objective Response Rate in 46 Patient Bavituximab Phase II Trial in Advanced Breast Cancer 5636 2Peregrine Pharmaceuticals Reports 61 25 Objective Response Rate in 46 Patient Bavituximab Phase II Trial in Advanced Breast Cancer 5636 3Peregrine Pharmaceuticals Reports 61 25 Objective Response Rate in 46 Patient Bavituximab Phase II Trial in Advanced Breast Cancer 5636 4Growing cartilage from stem cells 10456 1Informed Consent Goes Mobile Helping Patients and Clinicians Cut Confusion and Paperwork 59894 1Informed Consent Goes Mobile Helping Patients and Clinicians Cut Confusion and Paperwork 59894 2Informed Consent Goes Mobile Helping Patients and Clinicians Cut Confusion and Paperwork 59894 3
..., but many dinosaurs apparently had genomes no lar...ientists who,ve linked bone cell and genome size a...anding to gauge the genome sizes of 31 species of ...be measured from the fossil record. , The resea...f Reading, were led by Chris Organ and Scott V. Ed...
...hat give rise to a rare genetic disease, genetics ...hway that may have a broader role during human dev...on and autism. , An international team of researc...lia deLange syndrome (CdLS), a multisystem genetic...hildren. The disease varies from milder to more se...
...tion in mice results in an enhanced long-term memo...of the journal Cell, published by Cell Press. Thes...elopment of a drug to treat memory loss, according...ene that normally increases levels of a natural me...ive version of this gene showed improved performan...
Other Biology News:Despite their heft, many dinosaurs had surprisingly tiny genomes 2Gene found for rare disorder may reveal new pathway in mental retardation 2Mutation improves memory, may lead to memory-enhancing pill 2Mutation improves memory, may lead to memory-enhancing pill 3
Mouse Anti-Vancomycin Monoclonal Antibody, Unconjugated, Clone 2G1 from Abcam
Rat Anti-acetyl Salicylic Acid Polyclonal Antibody, Unconjugated from Abcam
Anti-Human I-FABP Polyclonal Antibody, Unconjugated from Cell Sciences
ProPrep BAC 960 from Biotech Support Group
Biology Products: